FDA issues supplement rules

Jun 23, 2007

The U.S. Food and Drug Administration has issued new government standards for the manufacture of vitamins and dietary supplements.

The standards are intended to ensure that dietary supplements "are produced in a quality manner, do not contain contaminants or impurities, and are accurately labeled," the FDA said Friday in a release.

"This rule helps to ensure the quality of dietary supplements so that consumers can be confident that the products they purchase contain what is on the label," said Commissioner of Food and Drugs Andrew C. von Eschenbach. "In addition, as a result of recent amendments to the Federal Food, Drug, and Cosmetic Act, by the end of the year, industry will be required to report all serious dietary supplement related adverse events to FDA."

The FDA said the agency is trying to prevent inclusion of the wrong ingredients; too much or too little of a dietary ingredient; contamination by substances such as natural toxins, bacteria, pesticides, glass, lead and other heavy metals; as well as improper packaging and labeling.

Copyright 2007 by United Press International

Explore further: Abhor asparagus and can't stand coffee? You may be a supertaster

add to favorites email to friend print save as pdf

Related Stories

Making quantum dots glow brighter

37 minutes ago

Researchers from the University of Alabama in Huntsville and the University of Oklahoma have found a new way to control the properties of quantum dots, those tiny chunks of semiconductor material that glow ...

Recommended for you

Errata frequently seen in medical literature

1 hour ago

(HealthDay)—Errata, including those that may materially change the interpretation of data, are frequent in medical publications, according to a study published in the August issue of The American Journal of ...

Seven US-based researchers share $1.3M eyesight prize

Sep 10, 2014

Seven U.S.-based researchers are sharing a €1 million ($1.3 million) prize from a Portuguese foundation for their work developing treatment for angiogenic diseases of the retina, the leading cause of blindness in the developed ...

User comments : 0